J Clin Neurol.  2017 Oct;13(4):442-443. 10.3988/jcn.2017.13.4.442.

Guillain-Barré and Miller Fisher Overlap Syndrome Mimicking Alimentary Botulism

Affiliations
  • 1Division of Neurorehabilitation, Geneva University Hospitals, Geneva, Switzerland. Gabriela.moreno@hcuge.ch
  • 2Division of Neurology, Geneva University Hospitals, Geneva, Switzerland.

Abstract

No abstract available.


MeSH Terms

Botulism*

Reference

1. Morgan ML, Law N, Espino Barros Palau A, Saeed U, Yalmanchili S, Lee AG. Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barré Syndrome. J Neuroophthalmol. 2014; 34:377–379.
Article
2. Fusco C, Bertani G, Scarano A, Giustina ED. Acute ophthalmoparesis associated with anti-GM1, anti-GD1a, and anti-GD1b antibodies after enterovirus infection in a 6-year-old girl. J Child Neurol. 2007; 22:432–434.
Article
3. Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol. 2014; 10:94–100.
Article
4. Simon O, Lacour A, Delval A, Beaume A, Vermersch P. Recurrent multiple cranial nerve palsy and anti-GD1a antibodies. Muscle Nerve. 2011; 43:447–448.
Article
5. Fujii D, Manabe Y, Takahasi Y, Narai H, Omori N, Kusunoki S, et al. A case of fisher-bickerstaff syndrome overlapped by guillain-barré syndrome. Case Rep Neurol. 2012; 4:212–215.
Article
6. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002; 125:2591–2625.
Article
7. Hamark C, Berntsson RP, Masuyer G, Henriksson LM, Gustafsson R, Stenmark P, et al. Glycans confer specificity to the recognition of ganglioside receptors by botulinum neurotoxin A. J Am Chem Soc. 2017; 139:218–230.
Article
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr